Experimental drug targets double trouble: heart failure meets lung pressure
NCT ID NCT07221513
Summary
This study is testing an experimental drug called JK07 in people who have both heart failure and high blood pressure in their lungs. About 30 adults will receive the drug to check if it's safe and how their bodies process it. The main goal is to see if JK07 can be tolerated and help control these serious conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Saint Francis Heart and Vascular Institute
RECRUITINGTulsa, Oklahoma, 74136, United States
Conditions
Explore the condition pages connected to this study.